PubMed

Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC; Diabetes Outcomes in Veterans Study (DOVES).

Diabetes Care. 2003 Jun;26(6):1759-63.PMID: 12766106 [PubMed - indexed for MEDLINE]Related articlesFree article

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.

Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group.

Diabetes Metab. 2003 Dec;29(6):587-94.PMID: 14707887 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study.

Hoffman RM, Shah JH, Wendel CS, Duckworth WC, Adam KD, Bokhari SU, Dalton C, Murata GH; Diabetes Outcome in Veterans Study.

Diabetes Care. 2002 Oct;25(10):1744-8.PMID: 12351471 [PubMed - indexed for MEDLINE]Related articlesFree article

Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Hoffman RM, Duckworth WC, Wendel CS, Shah JH; Diabetes Outcomes in Veterans Study.

Am J Med Sci. 2004 Jun;327(6):319-23.PMID: 15201644 [PubMed - indexed for MEDLINE]Related articles

Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

Harris MI; National Health and Nutrition Examination Survey (NHANES III).

Diabetes Care. 2001 Jun;24(6):979-82.PMID: 11375356 [PubMed - indexed for MEDLINE]Related articlesFree article

Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Duckworth WC, Shah JH, Wendel CS, Hoffman RM.

Clin Endocrinol (Oxf). 2004 Apr;60(4):451-6.PMID: 15049959 [PubMed - indexed for MEDLINE]Related articles

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.

Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK.

Diabetes Care. 2000 Oct;23(10):1478-85.PMID: 11023140 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.

Ozmen B, Boyvada S.

J Diabetes Complications. 2003 May-Jun;17(3):128-34.PMID: 12738396 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data.

Kovatchev BP, Cox DJ, Kumar A, Gonder-Frederick L, Clarke WL.

Diabetes Technol Ther. 2003;5(5):817-28.PMID: 14633347 [PubMed - indexed for MEDLINE]Related articles

Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing.

Allen BT, DeLong ER, Feussner JR.

Diabetes Care. 1990 Oct;13(10):1044-50.PMID: 2170088 [PubMed - indexed for MEDLINE]Related articles

The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies.

Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B, Greenfield S, Kaplan SH, Sacco M, Tognoni G, Valentini M, Nicolucci A; QuED Study Group.

Diabetes Care. 2001 Nov;24(11):1870-7.PMID: 11679449 [PubMed - indexed for MEDLINE]Related articlesFree article

Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman RR, Mant D, Kinmonth AL, Neil HA; DiGEM Trial Group.

Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50.PMID: 19254484 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control.

Meier JL, Swislocki AL, Lopez JR, Noth RH, Bartlebaugh P, Siegel D.

Am J Manag Care. 2002 Jun;8(6):557-65.PMID: 12068962 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control.

Soumerai SB, Mah C, Zhang F, Adams A, Barton M, Fajtova V, Ross-Degnan D.

Arch Intern Med. 2004 Mar 22;164(6):645-52.PMID: 15037493 [PubMed - indexed for MEDLINE]Related articlesFree article

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD study.

Halimi S, Charpentier G, Grimaldi A, Grenier JL, Baut F, Germain B, Magnette J.

Diabetes Metab. 2001 Dec;27(6):681-7.PMID: 11852377 [PubMed - indexed for MEDLINE]Related articlesFree article

Hemoglobin Glycosylation Index is not related with blood glucose.

Merino-Torres JF, Fajardo-Montañana C, Ferrer-García JC, Piñón-Sellés F.

J Diabetes Complications. 2003 Sep-Oct;17(5):249-53.PMID: 12954152 [PubMed - indexed for MEDLINE]Related articles

Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Duckworth WC, Shah JH, Wendel CS, Hoffman RM; Diabetes Outcomes in Veterans Study.

Diabetes Res Clin Pract. 2004 Jul;65(1):61-7.PMID: 15163479 [PubMed - indexed for MEDLINE]Related articles